Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Quantum Genesis AI (QTZM) EPS (Weighted Average and Diluted) (2024 - 2026)

Quantumzyme's EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at -$0.12 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) fell 14038.55% year-over-year to -$0.12; the TTM value through Jan 2026 reached -$0.12, down 3388.41%, while the annual FY2025 figure was -$0.01, 0.0% changed from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.12 in Q1 2026 per QTZM's latest filing, down from -$0.0 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.0 in Q1 2025 to a low of -$0.12 in Q1 2026.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$0.03, with a median of -$0.0 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 32.14% in 2025, then plummeted 14038.55% in 2026.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.0 in 2024, then skyrocketed by 32.14% to -$0.0 in 2025, then tumbled by 9275.64% to -$0.12 in 2026.
  • Per Business Quant, the three most recent readings for QTZM's EPS (Weighted Average and Diluted) are -$0.12 (Q1 2026), -$0.0 (Q4 2025), and -$0.0 (Q1 2025).